Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Hematology

Living with APS, Survivorship, and Monitoring

At a Glance

Living with Antiphospholipid Syndrome (APS) involves careful monitoring of your blood clotting levels (INR) and maintaining a consistent diet, especially Vitamin K intake if taking Warfarin. Managing lifestyle triggers like smoking and estrogen use is crucial to prevent future blood clots.

Living with Antiphospholipid Syndrome (APS) is a journey of vigilance. While the diagnosis marks a major shift in your life, it also provides the tools you need to prevent future complications. With the right management, most patients can maintain stability and lead full lives [1].

Mastering the INR and Your Diet

If you are taking Warfarin, the most important number in your life is your INR (International Normalized Ratio), which measures how long it takes your blood to clot. For most people with APS, the target range is between 2.0 and 3.0 [2].

  • The Vitamin K Balance: Consistency in your diet is vital. Warfarin works by blocking Vitamin K (which helps blood clot). If you drastically change how much Vitamin K you eat—found in leafy greens like spinach, kale, or broccoli—your INR can spike or crash. You do not need to avoid these healthy foods, but you do need to eat a consistent amount of them from week to week [2].
  • The APS Interference: In some cases, the very antibodies that cause APS can interfere with standard INR lab tests, making the result look higher or lower than it truly is [3]. If your levels are consistently hard to manage, your doctor might use a specialized test called chromogenic Factor X to get a more accurate reading [4].
  • Consistency is Key: Skipping doses or poor adherence to monitoring is one of the most common triggers for life-threatening complications like Catastrophic APS (CAPS) [5].

Beyond Blood Clots: Quality of Life

APS is often described as an “invisible” illness. You may be dealing with symptoms that aren’t caused by a major clot but are still part of the disease:

  • APS “Brain Fog”: Many patients report cognitive issues, such as memory lapses, difficulty concentrating, or “foggy” thinking [6].
  • Fatigue and Anxiety: Research shows that nearly all APS patients experience some degree of psychological impact, including elevated anxiety compared to healthy individuals [7][8].
  • Support Matters: Because quality of life is heavily impacted by the chronic nature of the disease, dedicated psychological evaluation and patient-specific education are essential parts of your care [9][1].

Protecting Your Future: Lifestyle as Medicine

The “Two-Hit” model reminds us that while you can’t change your antibodies (the first hit), you have significant control over the triggers (the second hit) [10]:

  1. Zero Smoking: Smoking damages the lining of your blood vessels and acts as a constant inflammatory trigger.
  2. Heart Health: Long-term APS is associated with a risk of heart valve thickening and accelerated cardiovascular disease [11]. Keeping your blood pressure, cholesterol, and weight in check helps protect your heart and blood vessels from the additional stress of APS [12].
  3. Eliminate Estrogen: As mentioned, avoiding estrogen-based birth control prevents an unnecessary secondary trigger for clotting [13].
  4. Movement: Prolonged sitting slows your blood flow. If you must travel, talk to your doctor about “bridging” medications or compression stockings to keep your blood moving.

By staying on top of your monitoring, maintaining diet consistency, and minimizing these triggers, you aren’t just “living with” APS—you are actively managing your risk and protecting your long-term health. Return to the Home Page to review core concepts.

Common questions in this guide

What should I eat while taking Warfarin for APS?
You do not need to avoid healthy foods like leafy greens, but you must eat a consistent amount of them from week to week. Drastic changes in your Vitamin K intake can cause your INR blood clotting levels to dangerously spike or crash.
Why are my INR levels fluctuating so much?
Sometimes the antibodies that cause APS can interfere with standard INR lab tests, making your results look artificially high or low. If this happens, your doctor may use a specialized test called chromogenic Factor X to get a more accurate reading.
Is brain fog a normal symptom of Antiphospholipid Syndrome?
Yes, many patients with APS report cognitive issues such as memory lapses, difficulty concentrating, or foggy thinking. These symptoms, along with fatigue and anxiety, are common and should be discussed with your healthcare team for supportive care.
What is a bridging plan for APS?
A bridging plan is a personalized medical strategy for managing your blood thinners if you need to briefly stop them for a sudden medical or dental procedure. This ensures you remain protected from blood clots during the interruption.
How can I prevent blood clots if I have APS?
You can actively manage your risk by maintaining consistent medication habits, eliminating smoking, prioritizing heart health, avoiding estrogen-based birth control, and staying active to keep your blood flowing.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.My INR seems to fluctuate a lot; are we using a test that is resistant to interference from my antibodies?
  2. 2.Is my cognitive 'brain fog' or fatigue typical for APS, and are there supportive therapies you can recommend?
  3. 3.What is my personalized 'bridging plan' if I ever need a sudden medical or dental procedure?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    The relationship between social support and health-related quality of life in patients with antiphospholipid (hughes) syndrome.

    Georgopoulou S, Efraimidou S, MacLennan SJ, et al.

    Modern rheumatology 2018; (28(1)):147-155 doi:10.1080/14397595.2017.1317319.

    PMID: 28463088
  2. 2

    Antiphospholipid Syndrome in Patients with Venous Thromboembolism.

    Pengo V, Denas G

    Seminars in thrombosis and hemostasis 2023; (49(8)):833-839 doi:10.1055/s-0042-1749590.

    PMID: 35728601
  3. 3

    The influence of antiphospholipid antibodies on prothrombin time and international normalized ratio: a scoping review.

    Vandevelde A, Amir M, Devreese KMJ

    Critical reviews in clinical laboratory sciences 2026; (63(5)):415-432 doi:10.1080/10408363.2025.2584522.

    PMID: 41332161
  4. 4

    Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case report.

    Varju L, Bagoly Z, Ajzner É, et al.

    Frontiers in immunology 2025; (16()):1591029 doi:10.3389/fimmu.2025.1591029.

    PMID: 40821827
  5. 5

    Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.

    Stammler R, Nguyen Y, Yelnik C, et al.

    Journal of thrombosis and haemostasis : JTH 2023; (21(5)):1258-1265 doi:10.1016/j.jtha.2023.02.007.

    PMID: 36792010
  6. 6

    Elucidating the Neuropsychiatric Phenomena of Antiphospholipid Syndrome in a 31-Year-Old Female.

    Jamal F, Kumar R, Hakobyan N

    Cureus 2024; (16(7)):e64856 doi:10.7759/cureus.64856.

    PMID: 39156266
  7. 7

    [Clinic behavior and therapeutic status of patients with antiphospholipid syndrome].

    Li Y, Liu X, Li G, et al.

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 2025; (57(6)):1107-1112.

    PMID: 41399073
  8. 8

    Frequency of psychological alterations in primary antiphospholipid syndrome: preliminary study.

    Sadetski M, Tourinho Moretto ML, Correia de Araujo RP, de Carvalho JF

    Lupus 2018; (27(5)):837-840 doi:10.1177/0961203317751063.

    PMID: 29301475
  9. 9

    Health-related quality of life impairment is equal for antiphospholipid syndrome whether primary or associated with systemic lupus erythematosus.

    Haladyj E, Matusiewicz A, Wysocki T, Olesinska M

    Reumatologia 2024; (62(4)):266-273 doi:10.5114/reum/192028.

    PMID: 39381730
  10. 10

    Antiphospholipid syndrome in pregnancy: a comprehensive literature review.

    Murvai VR, Galiș R, Panaitescu A, et al.

    BMC pregnancy and childbirth 2025; (25(1)):337 doi:10.1186/s12884-025-07471-w.

    PMID: 40128683
  11. 11

    Left Ventricle Libman-Sacks Endocarditis Secondary to Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Case Report.

    Yang ZH, Gong WQ, Liu Y, Zheng MJ

    The American journal of case reports 2025; (26()):e949826 doi:10.12659/AJCR.949826.

    PMID: 41129477
  12. 12

    Antiphospholipid Syndrome and the Kidney.

    Taghavi M, Jacobs L, Roccatello D, Sciascia S

    Kidney international reports 2025; (10(11)):3757-3772 doi:10.1016/j.ekir.2025.09.010.

    PMID: 41278338
  13. 13

    Aortic mural thrombosis with bilateral renal infarction in a woman taking dienogest for adenomyosis: A case report and literature review.

    Lee KY, Cheng CL, Chiang YC

    Taiwanese journal of obstetrics & gynecology 2025; (64(5)):842-846 doi:10.1016/j.tjog.2024.08.015.

    PMID: 40935463

This page provides educational information about living with Antiphospholipid Syndrome (APS). Always consult your doctor or hematologist for personalized monitoring and lifestyle advice.

Get notified when new evidence is published on Antiphospholipid syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.